Zoetis Inc. Inventory Write-down
Zoetis Inc. (ZTS) reported Inventory Write-down of $26.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-06
- Zoetis Inc. inventory write-down for the quarter ending 2026-06-30 was $13.00M, a 18.75% decline year-over-year.
- Zoetis Inc. inventory write-down for the quarter ending 2026-03-31 was $13.00M, a 31.58% decline year-over-year.
- Zoetis Inc. inventory write-down for the quarter ending 2025-12-31 was $16.00M, a 38.46% decline year-over-year.
- Zoetis Inc. inventory write-down for the quarter ending 2025-09-30 was $17.00M, a 41.38% decline year-over-year.
- Zoetis Inc. inventory write-down for fiscal 2025 was $68.00M, a 29.90% decline from fiscal 2024.
- Zoetis Inc. inventory write-down for fiscal 2024 was $97.00M, a 15.65% decline from fiscal 2023.
- Zoetis Inc. inventory write-down for fiscal 2023 was $115.00M, a 51.32% increase from fiscal 2022.
- Zoetis Inc. inventory write-down for fiscal 2022 was $76.00M, a 65.22% increase from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 6 month as first filed | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $26.00M 10-Q · filed 2026-08-06 | $42.00M derived: sum of 3 quarters · filed 2026-08-06 | $59.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $13.00M 10-Q · filed 2026-05-07 | $29.00M derived: sum of 2 quarters · filed 2026-05-07 | $46.00M derived: sum of 3 quarters · filed 2026-05-07 | $62.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $33.00M derived: sum of 2 quarters · filed 2026-02-12 | $49.00M derived: sum of 3 quarters · filed 2026-08-06 | $68.00M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $33.00M derived: sum of 2 quarters · filed 2026-08-06 | $52.00M 10-Q · filed 2025-11-04 | $78.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.00M 10-Q · filed 2026-08-06 | $32.00M 10-Q · filed 2025-08-05 | $61.00M derived: sum of 3 quarters · filed 2026-08-06 | $90.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $19.00M 10-Q · filed 2026-05-07 | $18.00M 10-Q · filed 2025-05-06 | $45.00M derived: sum of 2 quarters · filed 2026-05-07 | $74.00M derived: sum of 3 quarters · filed 2026-05-07 | $99.00M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $55.00M derived: sum of 2 quarters · filed 2026-02-12 | $80.00M derived: sum of 3 quarters · filed 2026-02-12 | $97.00M 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $54.00M derived: sum of 2 quarters · filed 2025-11-04 | $71.00M 10-Q · filed 2025-11-04 | $104.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $42.00M 10-Q · filed 2025-08-05 | $75.00M derived: sum of 3 quarters · filed 2026-02-12 | $110.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $17.00M 10-Q · filed 2025-05-06 | $50.00M derived: sum of 2 quarters · filed 2026-02-12 | $85.00M derived: sum of 3 quarters · filed 2026-02-12 | $116.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $68.00M derived: sum of 2 quarters · filed 2026-02-12 | $99.00M derived: sum of 3 quarters · filed 2026-02-12 | $115.00M 10-K · filed 2026-02-12 | |||
| 2023-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $66.00M derived: sum of 2 quarters · filed 2024-11-04 | $82.00M 10-Q · filed 2024-11-04 | $109.00M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $47.00M 10-Q · filed 2024-08-06 | $74.00M derived: sum of 3 quarters · filed 2025-02-13 | $92.00M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-03-31 | $16.00M 10-Q · filed 2024-05-02 | $43.00M derived: sum of 2 quarters · filed 2025-02-13 | $61.00M derived: sum of 3 quarters · filed 2025-02-13 | $83.00M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2022-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $45.00M derived: sum of 2 quarters · filed 2025-02-13 | $67.00M derived: sum of 3 quarters · filed 2025-02-13 | $76.00M 10-K · filed 2025-02-13 | |||
| 2022-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $40.00M derived: sum of 2 quarters · filed 2023-11-02 | $49.00M 10-Q · filed 2023-11-02 | $59.00M derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-06-30 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $31.00M 10-Q · filed 2023-08-08 | $41.00M derived: sum of 3 quarters · filed 2024-02-13 | $52.00M derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-03-31 | $9.00M 10-Q · filed 2023-05-04 | $19.00M derived: sum of 2 quarters · filed 2024-02-13 | $30.00M derived: sum of 3 quarters · filed 2024-02-13 | $44.00M derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2021-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $21.00M derived: sum of 2 quarters · filed 2024-02-13 | $35.00M derived: sum of 3 quarters · filed 2024-02-13 | $46.00M 10-K · filed 2024-02-13 | |||
| 2021-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $25.00M derived: sum of 2 quarters · filed 2022-11-03 | $36.00M 10-Q · filed 2022-11-03 | $85.00M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $25.00M 10-Q · filed 2022-08-04 | $74.00M derived: sum of 3 quarters · filed 2023-02-14 | $98.00M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $11.00M 10-Q · filed 2022-05-05 | $60.00M derived: sum of 2 quarters · filed 2023-02-14 | $84.00M derived: sum of 3 quarters · filed 2023-02-14 | $103.00M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $73.00M derived: sum of 2 quarters · filed 2023-02-14 | $92.00M derived: sum of 3 quarters · filed 2023-02-14 | $105.00M 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $43.00M derived: sum of 2 quarters · filed 2021-11-04 | $56.00M 10-Q · filed 2021-11-04 | $80.00M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $32.00M 10-Q · filed 2021-08-05 | $56.00M derived: sum of 3 quarters · filed 2022-02-15 | $71.00M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-03-31 | $13.00M 10-Q · filed 2021-05-06 | $37.00M derived: sum of 2 quarters · filed 2022-02-15 | $52.00M derived: sum of 3 quarters · filed 2022-02-15 | $67.00M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2019-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $39.00M derived: sum of 2 quarters · filed 2022-02-15 | $54.00M derived: sum of 3 quarters · filed 2022-02-15 | $68.00M 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $30.00M derived: sum of 2 quarters · filed 2020-11-05 | $44.00M 10-Q · filed 2020-11-05 | $61.00M derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $29.00M 10-Q · filed 2020-08-06 | $46.00M derived: sum of 3 quarters · filed 2021-02-16 | $58.00M derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-03-31 | $14.00M 10-Q · filed 2020-05-06 | $31.00M derived: sum of 2 quarters · filed 2021-02-16 | $43.00M derived: sum of 3 quarters · filed 2021-02-16 | $52.00M derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2018-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $29.00M derived: sum of 2 quarters · filed 2021-02-16 | $38.00M derived: sum of 3 quarters · filed 2021-02-16 | $54.00M 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $21.00M derived: sum of 2 quarters · filed 2019-11-07 | $37.00M 10-Q · filed 2019-11-07 | $45.00M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $25.00M 10-Q · filed 2019-08-06 | $33.00M derived: sum of 3 quarters · filed 2020-02-13 | $39.00M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | $16.00M 10-Q · filed 2019-05-02 | $24.00M derived: sum of 2 quarters · filed 2020-02-13 | $30.00M derived: sum of 3 quarters · filed 2020-02-13 | $54.00M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $14.00M derived: sum of 2 quarters · filed 2020-02-13 | $38.00M derived: sum of 3 quarters · filed 2020-02-13 | $54.00M 10-K · filed 2020-02-13 | |||
| 2017-10-01 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $30.00M derived: sum of 2 quarters · filed 2018-11-01 | $46.00M 10-Q · filed 2018-11-01 | $86.00M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2017-07-02 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $40.00M 10-Q · filed 2018-08-02 | $80.00M derived: sum of 3 quarters · filed 2019-02-14 | $110.00M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2017-04-02 | $16.00M 10-Q · filed 2018-05-02 | $56.00M derived: sum of 2 quarters · filed 2019-02-14 | $86.00M derived: sum of 3 quarters · filed 2019-02-14 | $105.00M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2016-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $70.00M derived: sum of 2 quarters · filed 2019-02-14 | $89.00M derived: sum of 3 quarters · filed 2019-02-14 | $105.00M 10-K · filed 2019-02-14 | |||
| 2016-10-02 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $49.00M derived: sum of 2 quarters · filed 2017-11-02 | $65.00M 10-Q · filed 2017-11-02 | $100.00M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-07-03 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $35.00M 10-Q · filed 2017-08-08 | $70.00M derived: sum of 3 quarters · filed 2018-02-15 | $75.00M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-04-03 | $16.00M 10-Q · filed 2017-05-04 | $51.00M derived: sum of 2 quarters · filed 2018-02-15 | $56.00M derived: sum of 3 quarters · filed 2018-02-15 | $75.00M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2015-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $40.00M derived: sum of 2 quarters · filed 2018-02-15 | $59.00M derived: sum of 3 quarters · filed 2018-02-15 | $94.00M 10-K · filed 2018-02-15 | |||
| 2015-09-27 | $5.00M 10-Q · filed 2015-11-05 | $24.00M derived: sum of 2 quarters · filed 2016-08-05 | $59.00M 10-Q · filed 2016-11-03 | $5.00M 10-Q · filed 2015-11-05 | |||
| 2015-06-28 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $37.00M 10-Q · filed 2016-08-05 | |||||
| 2015-03-29 | $18.00M 10-Q · filed 2016-05-06 | ||||||
| 2014-12-31 | $94.00M 10-K · filed 2017-02-16 | ||||||
| 2013-12-31 | $74.00M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |